16 September 2020 1 Min Read
Positive results from Lilly’s interim antibody trial data
Analysts expect antibody treatments could help some patients, as broad distribution of Covid-19 vaccine candidates is expected to be lengthy
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In